Asthma Study Enrolling

This study tests if an asthma treatment inhaler works the same when using a new, eco-friendly ingredient to push the medicine out. This study compares the newer version using hydrofluorodefin (HFO) with the current one using hydrofluoroalkane (HFA) to see if it's just as effective for adults with asthma.

Age 18 or Older

Participants must be 18 years or older to qualify.

Asthma diagnosed

Have been diagnosed with asthma for at least one year

Asthma Treatment

Use a daily low-dose ICS, ICS with LABA, or no regular inhaler.

Lung Function

Are able to complete lung function tests with accurate results

What to expect if you are volunteer to participate

Volunteering for a clinical study is a personal choice and a decision that you can change at any point within the study.

This study is approximately 14 to 15 weeks, and includes:

Screening and Run-In: 2-week period
Treatment Phases: Three 4-week treatment periods
Follow-Up: A final safety call 5 days post-treatment

Qualified participants may:

Receive compensation for time and travel
Receive no-cost study related care throughout the study
Receive access to study medication